{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:24:05Z","timestamp":1783448645533,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mater Sci: Mater Med"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s10856-020-06417-2","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T19:02:41Z","timestamp":1596654161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Magnetosome mediated oral Insulin delivery and its possible use in diabetes management"],"prefix":"10.1007","volume":"31","author":[{"given":"Varalakshmi","family":"Raguraman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Jayasri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7445-9573","authenticated-orcid":false,"given":"K.","family":"Suthindhiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,5]]},"reference":[{"key":"6417_CR1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.addr.2016.01.010","volume":"101","author":"M Elena","year":"2016","unstructured":"Elena M, Matoori S, Leroux J-C. Oral delivery of macromolecular drugs: where we are after almost 100 years of attempts. Adv Drug Deliv Rev. 2016;101:108\u201321.","journal-title":"Adv Drug Deliv Rev."},{"key":"6417_CR2","doi-asserted-by":"crossref","unstructured":"P\u00e9rez YA, Urista CM, Mart\u00ednez JI, Nava MDCD, Rodr\u00edguez FAR. Functionalized polymers for enhance oral bioavailability of sensitive molecules. Polymers. 2016;8(6):214.","DOI":"10.3390\/polym8060214"},{"key":"6417_CR3","first-page":"413","volume":"24.4","author":"M Abdul","year":"2016","unstructured":"Abdul M. et al. A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives. Saudi Pharm J. 2016;24.4:413\u201328.","journal-title":"Saudi Pharm J"},{"key":"6417_CR4","first-page":"43","volume":"12.1","author":"B Ana","year":"2016","unstructured":"Ana B. et al. Nanostructured lipid carriers: Promising drug delivery systems for future clinics. Nanomedicine. 2016;12.1:43\u2013161.","journal-title":"Nanomedicine"},{"issue":"2","key":"6417_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.nano.2011.05.016","volume":"8","author":"S Parveen","year":"2012","unstructured":"Parveen S, Misra R, Sahoo SK. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine: Nanotechnol Biol Med. 2012;8(2):147\u201366.","journal-title":"Nanomedicine: Nanotechnol Biol Med"},{"key":"6417_CR6","first-page":"1102","volume":"21.11","author":"P Ashaben","year":"2014","unstructured":"Ashaben P. et al. Recent advances in protein and peptide drug delivery: a special emphasis on polymeric nanoparticles. Protein Pept Lett. 2014;21.11:1102\u201320.","journal-title":"Protein Pept Lett"},{"key":"6417_CR7","doi-asserted-by":"crossref","unstructured":"Ahmed TA, Aljaeid BM. Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pha rmaceutical drug delivery. Drug Des Devel Ther. 2016;10:483.","DOI":"10.2147\/DDDT.S99651"},{"key":"6417_CR8","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1016\/j.bmc.2009.02.043","volume":"17(8)","author":"AH Faraji","year":"2009","unstructured":"Faraji AH, Wipf P. Nanoparticles in cellular drug delivery. Bioorg Med Chem. 2009;17(8):2950\u201362.","journal-title":"Bioorg Med Chem"},{"key":"6417_CR9","doi-asserted-by":"crossref","unstructured":"Montanari Stefano, Antonietta Gatti M. Nanopathology: the health impact of nanoparticles. CRC Press, Boca Raton, Florida, USA; 2016.","DOI":"10.1201\/b11133"},{"key":"6417_CR10","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.addr.2007.04.007","volume":"59.6","author":"AJ Almeida","year":"2007","unstructured":"Almeida AJ, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv. Drug Deliv Rev. 2007;59.6:478\u201390.","journal-title":"Adv. Drug Deliv Rev."},{"key":"6417_CR11","first-page":"237.","volume":"4","author":"HK El\u00e7io\u011flu","year":"2014","unstructured":"El\u00e7io\u011flu HK, Sezer AD. Nanoparticle insulin drug delivery\u2014applications and new aspects. Appl Nanotechnol Drug Deliv. 2014;4:237.","journal-title":"Appl Nanotechnol Drug Deliv"},{"key":"6417_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-015-0136-y","volume":"13.1","author":"G Sharma","year":"2015","unstructured":"Sharma G. et al. Nanoparticle based Insulin delivery system: the next generation efficient therapy for Type 1 diabetes. J Nanobiotechnol. 2015;13.1:74","journal-title":"J Nanobiotechnol"},{"key":"6417_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.addr.2015.12.022","volume":"103","author":"S Alejandro","year":"2016","unstructured":"Alejandro S, Augustine R. Challenges in oral drug delivery of antiretrovirals and the innovative strategies to overcome them. Adv Drug Deliv Rev. 2016;103:105\u201320.","journal-title":"Adv Drug Deliv Rev."},{"key":"6417_CR14","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.addr.2012.10.007","volume":"65","author":"Y Yun","year":"2013","unstructured":"Yun Y, Cho WY, Park K. Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery. Adv Drug Deliv Rev. 2013;65:822\u201332.","journal-title":"Adv Drug Deliv Rev."},{"key":"6417_CR15","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.nano.2015.02.018","volume":"11.5","author":"S Hua","year":"2015","unstructured":"Hua S. et al. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue. Nanomed Nanotechnol. 2015;11.5:1117\u201332.","journal-title":"Nanomed Nanotechnol"},{"key":"6417_CR16","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.msec.2016.07.049","volume":"68","author":"JJ Jacob","year":"2016","unstructured":"Jacob JJ, Suthindhiran K. Magnetotactic bacteria and magnetosomes\u2014scope and challenges. Mater Sci Eng C Mater. 2016;68:919\u201328.","journal-title":"Mater Sci Eng C Mater"},{"issue":"4","key":"6417_CR17","first-page":"2161","volume":"2","author":"S Dasdag","year":"2014","unstructured":"Dasdag S, Bektas H. Magnetotactic bacteria and their application in medicine. J Phys Chem Biophys. 2014;2(4):2161\u20130398.","journal-title":"J Phys Chem Biophys."},{"key":"6417_CR18","doi-asserted-by":"crossref","unstructured":"Raguraman, V, Suthindhiran K, Comparative ecotoxicity assessment of magnetosomes and magnetite nanoparticles, Int J Environ Health Res. 2019:1\u201313.","DOI":"10.1080\/09603123.2019.1570489"},{"key":"6417_CR19","doi-asserted-by":"crossref","unstructured":"Hungate, RE. Chapter IV A roll tube method for cultivation of strict anaerobes. Methods Microbiol. 1969;3:117\u201332.","DOI":"10.1016\/S0580-9517(08)70503-8"},{"key":"6417_CR20","doi-asserted-by":"publisher","first-page":"R198","DOI":"10.1088\/0022-3727\/36\/13\/203","volume":"36.13","author":"CC Berry","year":"2003","unstructured":"Berry CC, Adam SGC. Functionalisation of magnetic nanoparticles for applications in biomedicine. J Phys D: Appl Phys. 2003;36.13:R198.","journal-title":"J Phys D: Appl Phys"},{"key":"6417_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1472-765X.2007.02143.x","volume":"45.1","author":"L Xiang","year":"2007","unstructured":"Xiang L. et al. Purified and sterilized magnetosomes from Magnetospirillum gryphiswaldense MSR\u20101 were not toxic to mouse fibroblasts in vitro. Lett Appl Microbiol. 2007;45.1:75\u201381.","journal-title":"Lett Appl Microbiol"},{"key":"6417_CR22","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1126\/science.203.4387.1355","volume":"203.4387","author":"RB Frankel","year":"1979","unstructured":"Frankel RB, Blakemore RP, Wolfe RS. Magnetite in freshwater magnetotactic bacteria. Science. 1979;203.4387:1355\u20136.","journal-title":"Science."},{"key":"6417_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-017-0780-z","volume":"7.2","author":"T Revathy","year":"2017","unstructured":"Revathy T, Jayasri MA, Suthindhiran K. Toxicity assessment of magnetosomes in different models. 3 Biotech. 2017;7.2:126.","journal-title":"3 Biotech"},{"issue":"8","key":"6417_CR24","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s11095-007-9257-9","volume":"24","author":"DR Bhumkar","year":"2007","unstructured":"Bhumkar DR, Joshi HM, Sastry M, Pokharkar VB. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of Insulin. Pharm. Res. 2007;24(8):1415\u201326.","journal-title":"Pharm. Res."},{"key":"6417_CR25","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.ijpharm.2014.07.049","volume":"473.1-2","author":"T Andreani","year":"2014","unstructured":"Andreani T. et al. Preparation and characterization of PEG-coated silica nanoparticles for oral Insulin delivery. Int J Pharm. 2014;473.1-2:627\u201335.","journal-title":"Int J Pharm."},{"key":"6417_CR26","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.ijbiomac.2014.08.040","volume":"72","author":"M Piyasi","year":"2015","unstructured":"Piyasi M. et al. pH-sensitive chitosan\/alginate core-shell nanoparticles for efficient and safe oral Insulin delivery. Int J Biol Macromol. 2015;72:640\u20138.","journal-title":"Int J Biol Macromol"},{"key":"6417_CR27","first-page":"1047","volume":"29.2","author":"PS Unnikrishnan","year":"2017","unstructured":"Unnikrishnan PS, Jayasri MA. Antidiabetic studies of Chaetomorpha antennina extract using experimental models. J Appl Psychol. 2017;29.2:1047\u201356.","journal-title":"J Appl Psychol."},{"key":"6417_CR28","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0169-409X(02)00025-X","volume":"54","author":"KD Hinds","year":"2002","unstructured":"Hinds KD, Kim SW. Effects of PEG conjugation on Insulin properties. Adv Drug Deliv Rev. 2002;54:505\u201330.","journal-title":"Adv Drug Deliv Rev."},{"key":"6417_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jconrel.2016.04.012","volume":"232","author":"L Marlene","year":"2016","unstructured":"Marlene L. et al. Dual chitosan\/albumin-coated alginate\/dextran sulfate nanoparticles for enhanced oral delivery of Insulin. J Control Release. 2016;232:29\u201341.","journal-title":"J Control Release"},{"key":"6417_CR30","first-page":"1342","volume":"33.6","author":"F Pedro","year":"2015","unstructured":"Pedro F. et al. Polymer-based nanoparticles for oral Insulin delivery: revisited approaches. Biotechnol Adv. 2015;33.6:1342\u201354.","journal-title":"Biotechnol Adv."},{"key":"6417_CR31","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1359-0286(02)00117-1","volume":"6","author":"HL Meredith","year":"2002","unstructured":"Meredith HL, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci. 2002;6:319\u201327.","journal-title":"Curr Opin Solid State Mater Sci."},{"key":"6417_CR32","doi-asserted-by":"publisher","first-page":"9826","DOI":"10.1016\/j.biomaterials.2011.08.087","volume":"32","author":"M-C Chen","year":"2011","unstructured":"Chen M-C. et al. A review of the prospects for polymeric nanoparticle platforms in oral Insulin delivery. Biomaterials. 2011;32:9826\u201338.","journal-title":"Biomaterials"},{"issue":"S1","key":"6417_CR33","doi-asserted-by":"crossref","first-page":"S449","DOI":"10.1155\/2010\/147824","volume":"7","author":"BA Moussa","year":"2010","unstructured":"Moussa BA, Farouk F, Azzazy HME. A validated RP-HPLC method for the determination of recombinant human Insulin in bulk and pharmaceutical dosage form. J Chem. 2010;7(S1):S449\u201357.","journal-title":"J Chem"},{"key":"6417_CR34","first-page":"788","volume":"36.5","author":"MA Singh","year":"2016","unstructured":"Singh MA. Magnetotactic bacteria: nanodrivers of the future. Crit Rev Biotechnol. 2016;36.5:788\u2013802.","journal-title":"Crit Rev Biotechnol."},{"key":"6417_CR35","first-page":"1700413","volume":"38.23","author":"X Jing","year":"2017","unstructured":"Jing X, Li A, Li J. Advances in pH\u2010sensitive polymers for smart insulin delivery. Macromol Rapid Commun. 2017;38.23:1700413.","journal-title":"Macromol Rapid Commun."},{"key":"6417_CR36","first-page":"89","volume":"9.1","author":"DU Rinku","year":"2014","unstructured":"Rinku DU, Paknikar KM. Zinc oxide nanoparticles show antidiabetic activity in streptozotocin-induced Type 1 and 2 diabetic rats. Nanomedicine. 2014;9.1:89\u2013104.","journal-title":"Nanomedicine."},{"key":"6417_CR37","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jddst.2018.10.022","volume":"49","author":"S Naskar","year":"2019","unstructured":"Naskar S, Sharma S, Koutsu K. Chitosan-based nanoparticles: an overview of biomedical applications and its preparation. J Drug Deliv Sci Technol. 2019;49:66\u201381.","journal-title":"J Drug Deliv Sci Technol"}],"container-title":["Journal of Materials Science: Materials in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-020-06417-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10856-020-06417-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-020-06417-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T10:37:25Z","timestamp":1723372645000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10856-020-06417-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["6417"],"URL":"https:\/\/doi.org\/10.1007\/s10856-020-06417-2","relation":{},"ISSN":["0957-4530","1573-4838"],"issn-type":[{"value":"0957-4530","type":"print"},{"value":"1573-4838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"31 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"75"}}